- Home
- TEL vs ALC Comparison
TEL vs ALC Comparison
Compare TEL & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TEL | ALC |
|---|---|---|
| Founded | 1941 | 1945 |
| Country | Ireland | Switzerland |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Ophthalmic Goods |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.6B | 39.0B |
| IPO Year | 2007 | N/A |
Fundamental Metrics
Financial Performance| Metric | TEL | ALC |
|---|---|---|
| Price | $231.02 | $81.76 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 12 |
| Target Price | ★ $258.00 | $88.71 |
| AVG Volume (30 Days) | ★ 1.8M | 1.2M |
| Earning Date | 01-21-2026 | 02-24-2026 |
| Dividend Yield | ★ 1.23% | 0.27% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 6.16 | 2.10 |
| Revenue | ★ $17,262,000,000.00 | $10,185,000,000.00 |
| Revenue This Year | $12.57 | $5.76 |
| Revenue Next Year | $7.40 | $7.24 |
| P/E Ratio | ★ $37.59 | $37.60 |
| Revenue Growth | ★ 8.94 | 4.34 |
| 52 Week Low | $116.30 | $71.55 |
| 52 Week High | $250.67 | $99.20 |
Technical Indicators
Market Signals| Indicator | TEL | ALC |
|---|---|---|
| Relative Strength Index (RSI) | 49.55 | 61.33 |
| Support Level | $227.37 | $76.74 |
| Resistance Level | $237.17 | $80.88 |
| Average True Range (ATR) | 4.81 | 1.08 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 60.73 | 89.53 |
Price Performance
Historical ComparisonAbout TEL TE Connectivity Ltd. New Switzerland Registered Shares
TE Connectivity is the largest electrical connector supplier in the world, supplying interconnect and sensor solutions to the transportation, industrial, and communications markets. With operations in 150 countries and over 500,000 stock-keeping units, TE has a broad portfolio that forms the electrical architecture of its end customers' cutting-edge innovations.
About ALC Alcon Inc.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.